AU1748792A - Phosphorus containing compounds as inhibitors of retroviruses - Google Patents

Phosphorus containing compounds as inhibitors of retroviruses

Info

Publication number
AU1748792A
AU1748792A AU17487/92A AU1748792A AU1748792A AU 1748792 A AU1748792 A AU 1748792A AU 17487/92 A AU17487/92 A AU 17487/92A AU 1748792 A AU1748792 A AU 1748792A AU 1748792 A AU1748792 A AU 1748792A
Authority
AU
Australia
Prior art keywords
retroviruses
inhibitors
containing compounds
phosphorus containing
phosphorus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17487/92A
Inventor
Jed F. Fisher
Jackson B. Hester
Linda Louise Maggiora
Tomi Kim Sawyer
Suvit Thaisrivongs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU1748792A publication Critical patent/AU1748792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU17487/92A 1991-04-04 1992-03-27 Phosphorus containing compounds as inhibitors of retroviruses Abandoned AU1748792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67950891A 1991-04-04 1991-04-04
US679508 1991-04-04

Publications (1)

Publication Number Publication Date
AU1748792A true AU1748792A (en) 1992-11-02

Family

ID=24727186

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17487/92A Abandoned AU1748792A (en) 1991-04-04 1992-03-27 Phosphorus containing compounds as inhibitors of retroviruses

Country Status (5)

Country Link
EP (1) EP0578745A1 (en)
JP (1) JPH06506463A (en)
AU (1) AU1748792A (en)
MX (1) MX9201546A (en)
WO (1) WO1992017490A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679688A (en) * 1992-03-11 1997-10-21 Narhex Limited Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US6258806B1 (en) 1992-03-11 2001-07-10 Narhex Limited Amine derivatives of oxo- and hydroxy- substituted hydrocarbons

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643878A (en) * 1991-09-12 1997-07-01 Ciba-Geigy Corporation 5-amino-4-hydroxyhexanoic acid derivatives
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
US5965532A (en) 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
EA002146B1 (en) 1997-02-26 2001-12-24 Пфайзер Инк. Heteroaryl-hexanoicacid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alfa binding to its ccr1 receptor
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
US6100234A (en) * 1997-05-07 2000-08-08 Tufts University Treatment of HIV
JP2001518290A (en) 1997-09-29 2001-10-16 ポイント セラピューティクス， インコーポレイテッド Stimulation of hematopoietic cells in vitro
SK9192000A3 (en) * 1997-12-17 2001-03-12 Merck & Co Inc Integrin receptor antagonists
NZ507730A (en) 1998-05-04 2004-02-27 Point Therapeutics Inc Hematopoietic stimulation
EP1084129B1 (en) 1998-06-05 2003-01-22 Point Therapeutics, Inc. Cyclic boroproline compounds
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
US20030039661A1 (en) * 2001-03-02 2003-02-27 Teresa Aja Methods, compositions and kits for preserving antigenicity
CA2453451A1 (en) 2001-07-10 2003-01-23 Elan Pharmaceuticals, Inc. Aminediols for the treatment of alzheimer's disease

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679688A (en) * 1992-03-11 1997-10-21 Narhex Limited Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US5942504A (en) * 1992-03-11 1999-08-24 Narhex Limited Amine derivatives of oxo- and hydroxy- substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US6258806B1 (en) 1992-03-11 2001-07-10 Narhex Limited Amine derivatives of oxo- and hydroxy- substituted hydrocarbons

Also Published As

Publication number Publication date
JPH06506463A (en) 1994-07-21
EP0578745A1 (en) 1994-01-19
WO1992017490A1 (en) 1992-10-15
MX9201546A (en) 1993-02-01

Similar Documents

Publication Publication Date Title
AU1748792A (en) Phosphorus containing compounds as inhibitors of retroviruses
IL86464A0 (en) Phosphorus-containing hmg-coa reductase inhibitor compounds and pharmaceutical compositions containing the same
AU1143288A (en) Lipoxygenase inhibiting compounds
AU7168696A (en) Inhibitors of regulatory pathways
AU635415B2 (en) Use of n-alkyl-lactams as crystallization inhibitors
AU581887B2 (en) Ethanolamine compounds
AU569719B2 (en) Phosphorous compounds as inhibitors of enkephalinases
AU3634095A (en) Inhibition of hemoflagellates by camptothecin compounds
AU4680797A (en) Preparation of substituted guanidines
AU5958394A (en) Coumarin derivatives as retroviral inhibitors
AU3192289A (en) Nucleosidetype compounds which are phosphodiesterase inhibitors
IL86463A0 (en) Phosphorus-containing hmg-coa reductase inhibitor compounds and pharmaceutical compositions containing the same
GB9320785D0 (en) Dibenzylheterocyclic or dibenzylcycloalkyl derivatives as inhibitors of hiv intergrase
AU1875988A (en) 5-aralkyl-2-mercaptoimidazole derivatives as dopamine-beta- hydroxylase inhibitors
GR890100859A (en) Beta-aminoethyl substituted phenyl compounds and anti-inflammatory or analgesic compositions containing them
AU7683294A (en) Composition containing phosphate derivatives
AU4344689A (en) N-imidazolyl-and n-imidazolylmethyl-derivatives of substituted bicyclic compounds
AU5323694A (en) 17beta -carboxanilides of 4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors
AU2577088A (en) Tert-butyl phenyl compounds useful as anti-inflammatory agents
AU1797392A (en) Pla2 inhibitors
AU5184393A (en) Substituted derivatives of diaminophthalimide
AU7390294A (en) Biocidal compositions containing organoboron compounds
AU3151489A (en) Compounds for inhibiting the biosynthesis of lipoxygenase -derived metabolites of arachidonic acid
AU1142192A (en) Process for the preparation of 13c-labelled compounds
GB8814422D0 (en) Analgesic compounds & compositions